Basic Information
Zynerba Pharmaceuticals is dedicated to developing next-generation transdermal cannabinoid therapies for patients with rare neuropsychiatric disorders by manufacturing drugs and enhancing the permeation of transdermal cannabinoid candidates to modulate pathways in the central nervous system.
Zynerba Pharmaceuticals, Inc.
Pennsylvania,United States of America
51~100 people
January 01, 2007
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios